Immunovia names new senior director investor relations and corporate communications.

M2 EQUITYBITES-November 26, 2021-Immunovia names new senior director investor relations and corporate communications

(C)2021 M2 COMMUNICATIONS http://www.m2.com

Sweden based diagnostic company Immunovia AB (publ) reported on Friday the election of Tobias Bülow as the new senior director of its Investor Relations and Corporate Communications with effect from 15 January 2022.

Most recently, Bülow has served as director of Investor Relations at Mycronic AB (publ).

Previously, Bülow was employed as director of Financial Communications...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT